So proud to be an OG mentee of this titan of science, my hocam, @ghotamis who has been elected into the National Academy of Sciences. Here is us as babies in '03. The best. @HarvardChanSPH@theNASciences
We are extremely proud and thrilled to announce our very own Dr. Hotamışlıgil @ghotamis has been elected to the National Academy of Sciences!! Congratulations on this outstanding achievement and recognition 👏👏👏😊https://t.co/FczVnkTKru
We thank all of the nearly 23,000 people attending this year's AACR Annual Meeting in person and online, as well as the more than 5,500 who shared about #AACR26 on social media, generating 224.4 million impressions so far.
Amazing opportunity @AACR to share our experience in building the @MeDOCResearch Consortium to fill the gaps in understanding the obesity-cancer risk connection during the @theNCI - @NIH session today! Read more about this innovative transdisciplinary approach-Lam et al @JNCI_Now
Did you know metabolic issues linked to obesity can raise cancer risk? 🎗️The NCI/NIH Consortia Initiative MeDOC, is bringing together experts across disciplines to tackle this head-on. Learn more at today's NCI-Sponsored session from 10:15-11:15 PST at #AACR26.
Checkout the posters we presented today (4/20)!
Circulating Sphingolipids and Colorectal Cancer Risk Among African American Adults presented by Sara Salas
Excellent showing of Memphians from @UTHSC_Cancer - Center for Cancer Research from faculty to trainees at #AACR26 with many posters and speakers! Congrats to @RachelSPerkins1 Rachel Perkins for her @AACR Faculty Scholar in Cancer Research Award! 🎉
So happy to catch up on the successes of my former doctoral student Mehdi @ChaibImmune at #AACR26 now a postdoc at MD Anderson. It was amazing to see his work highlighted during Jim Allison’s lifetime achievement award! Congrats Mehdi! So proud!
Be sure to checkout the MeDOC Consortium's poster at #AACR this afternoon (4/21 2-5pm PST)! The poster will be set up in Section 4, Board 26
MeDOC-KB: Knowledge Base for Unraveling the Metabolic Links Between Obesity-Related Cancers presented by The GW-CC
Thrilled for @JJMilnerLab to be awarded this @AACR Trailblazer award! So happy to run into my former “roton” rotation student who has gone on to great things!! #Aacr26
These @AACR Trailblazer Grants will equip early-stage and mid-career investigators with the resources they need to conduct paradigm-shifting research that will help define the future of cancer research. We thank @Pfizer for their impactful gift that made these grants possible.
Big things are happening! MeDOC Consortium members are at #AACR2026, sharing groundbreaking research on obesity-related cancers. Posters will be presented this afternoon in Sections 36 (#14) and 54 (#8).
Proud to help drive real change in cancer research—stay tuned for updates!
Be sure to checkout the MeDOC Consortium's poster at #AACR this afternoon (4/20 2-5pm)! The poster will be set up in Section 36, Board 14
Obesity, metabolic dysfunction, and cancer risk: Uncovering the metabolic landscape presented by the #MeDOC Consortium
Simultaneously released at #AACR26 our new collaborative study investigating the impact of weight loss and omega-3 PUFA on the #microbiome in women at high-risk for #breastcancer https://t.co/9ITADeUDFO
Join Lily Guenther, MD, Molecular Oncology, from 3-3:30 p.m. at booth 2346. She will share her expertise in pediatric sarcoma ahead of her presentation at the Interface of Radiation Science and Pediatric Oncology Town Hall tonight at 6:30 p.m.
#AACR26#StJudeResearch
Congrats to my postdoctoral fellows Dr. Sandesh Marathe @SMaratheTweets and Dr. Naveed Pervaiz on receiving Travel Awards at the @UTHSC_CGHS 18th Annual Postdoctoral Research Showcase to attend the 2026 @GordonConf on #Immunometabolism to share exciting @MeDOCResearch findings!
Conserved candidate genes (RASSF3, GNS, and TBC1D30) associated with poorer overall survival in BC patients—highlighting new risk biomarkers and potential therapeutic targets.
Triple negative breast cancer (#TNBC) remains an aggressive subtype in need of advances to predict risk and improve outcomes. Using systems genetics in a novel preclinical model in the BXD recombinant inbred family we identified genetic modifiers of TNBC onset and burden.